Executive Summary
The 10 proxy filings reveal a mixed landscape for executive compensation and corporate governance, with several critical inflection points. Capri Holdings and Cavco Industries stand out with strong operational turnarounds—Capri returned to full-year profitability and positive free cash flow following the Versace sale, while Cavco reported record revenue of $2.2 billion (+15.9% YoY in income) and completed its largest-ever acquisition.
However, significant risks emerge: Plum Acquisition Corp faces imminent liquidation (July 16 deadline) unless shareholders approve an extension, and Silexion Therapeutics is fighting for Nasdaq compliance with dilutive financing. Insider activity is sparse but notable—Kyndryl's CEO saw a 29% target pay increase to $18M LTI, while FuboTV's multi-year compensation data shows stability. Capital allocation trends diverge sharply: Cavco aggressively repurchased $160M in stock, while Silexion and Plum are burning cash. Sector themes center on governance alignment (Nomura ETF Trust merging boards), SPAC survival pressures, and the growing use of performance-based equity (PSUs with TSR modifiers) to link pay to shareholder returns.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEF 14A
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from June 15, 2026.
Investment Signals (10)
- Capri Holdings ↓ (BULLISH)▲
Returned to full-year profitability and positive free cash flow in Fiscal 2026, driven by Michael Kors and Jimmy Choo; Versace sale strengthened balance sheet—strong turnaround signal
- Cavco Industries ↓ (BULLISH)▲
Record annual revenue of $2.2B, income before taxes up 15.9% YoY, diluted EPS up 15.8%, completed largest-ever acquisition (American Homestar) and repurchased $160M in stock—execution and capital return
- Kyndryl Holdings ↓ (BULLISH)▲
CEO Martin Schroeter's target pay increased to $1.45M base + 225% bonus + $18M LTI (94% variable); new PSUs tied to 3-year cumulative adjusted OCF with relative TSR modifier—strong alignment with shareholder value creation
-
Board recommends FOR all proposals; Peter Swinburn retiring, refreshing board; virtual-only meeting suggests cost discipline—steady governance [NEUTRAL/BULLISH]
-
Seeking to expand board from 5 to 7 trustees with two new independent nominees (Hayes, Vroegop) starting Oct 1, 2026—governance improvement without cost increase [NEUTRAL/BULLISH]
- Invesco Senior Income Trust ↓ (NEUTRAL)▲
Sole proposal is trustee election; no cumulative voting—low governance risk but limited shareholder influence
- Nomura ETF Trust ↓ (NEUTRAL)▲
Proposing unified board for 9 ETFs and mutual funds to align governance; no cost increase to shareholders—efficiency play
- FuboTV Inc. ↓ (NEUTRAL)▲
Filing covers CEO David Gandler's compensation for 2020-2025; virtual meeting July 28—stability in leadership pay structure
- Plum Acquisition Corp IV ↓ (BEARISH)▲
Seeking extension to Jan 16, 2027 (from July 16, 2026) to complete CTR deal; if not approved, liquidation at ~$10.67/share, warrants expire worthless—high-stakes binary event
- Silexion Therapeutics ↓ (BEARISH)▲
Proposing 10M share increase to fund Phase 2/3 trials for SIL 204; previous issuances consumed capacity—dilution risk outweighs clinical upside
Risk Flags (10)
- Plum Acquisition Corp/Liquidation Risk↓ [HIGH RISK]▼
If extension not approved by 2/3 majority at July 2 meeting, SPAC liquidates at ~$10.67/share; warrants expire worthless—imminent deadline July 16, 2026
- Silexion Therapeutics/Nasdaq Compliance↓ [HIGH RISK]▼
Needs shareholder approval to maintain $2.5M minimum equity; 10M share increase will cause significant dilution; prior issuances (Warrant Inducement, ATM, Moringa Note) already consumed capacity
- Silexion Therapeutics/Dilution↓ [HIGH RISK]▼
Authorized share increase does not cause dilution itself, but subsequent issuances to meet Nasdaq requirements will dilute existing holders and likely reduce share price
- Plum Acquisition Corp/No Deal↓ [HIGH RISK]▼
If extension fails and no deal closes, public shareholders get ~$10.67/share but warrants expire worthless—asymmetric downside for warrant holders
- Cavco Industries/Market Headwinds↓ [MEDIUM RISK]▼
Despite record results, faces evolving market conditions, interest rate dynamics, and housing affordability challenges—macro risk to growth trajectory
- Capri Holdings/No Specific Figures↓ [MEDIUM RISK]▼
Filing lacks revenue/earnings details despite claiming profitability; focus on future growth acceleration without concrete numbers—transparency gap
- Kyndryl Holdings/Executive Turnover↓ [MEDIUM RISK]▼
CFO, General Counsel, CHRO transitions effective February 2026—leadership instability could disrupt strategy execution
- FuboTV Inc./No Insider Activity↓ [LOW RISK]▼
No insider buying or selling disclosed in proxy; lack of management conviction signal
- Driven Brands Holdings/Board Retirement↓ [LOW RISK]▼
Peter Swinburn retiring; board refresh could signal strategic shift or governance concerns
- ▼
No cumulative voting; each share one vote—limited minority shareholder influence
Opportunities (10)
- Cavco Industries/Record Growth + Buyback↓ (OPPORTUNITY)◆
Record $2.2B revenue, 15.9% income growth, $160M buyback; new Arizona facility breaking ground—strong operational momentum and capital return
- Capri Holdings/Turnaround Play↓ (OPPORTUNITY)◆
Return to profitability and positive FCF after Versace sale; balance sheet strengthened—potential re-rating if growth accelerates
- Kyndryl Holdings/Performance-Linked Pay↓ (OPPORTUNITY)◆
CEO compensation 94% variable with PSUs tied to 3-year OCF and TSR modifier—strong alignment with long-term shareholder value
- Nomura ETF Trust/Governance Alignment↓ (OPPORTUNITY)◆
Unified board for 9 ETFs and mutual funds; no cost increase—efficiency gain could improve fund performance and attract inflows
- HSBC Funds/New Independent Trustees↓ (OPPORTUNITY)◆
Adding Hayes and Vroegop as independent trustees starting Oct 1, 2026—governance upgrade could enhance shareholder confidence
- Driven Brands Holdings/Board Refresh↓ (OPPORTUNITY)◆
Retirement of Peter Swinburn opens door for new strategic direction; virtual meeting suggests cost discipline
- Plum Acquisition Corp IV/Arbitrage Opportunity↓ (OPPORTUNITY)◆
If extension approved, SPAC gets 6-month runway to close CTR deal; current trust value ~$10.67/share provides floor for common shares
- Silexion Therapeutics/Clinical Catalyst↓ (OPPORTUNITY)◆
Approval of share increase enables Phase 2/3 trials for SIL 204; if successful, upside could outweigh dilution risk—high-risk/high-reward
- FuboTV Inc./Stable Leadership↓ (OPPORTUNITY)◆
CEO compensation data 2020-2025 shows consistency; virtual meeting July 28—potential for strategic updates
- Invesco Senior Income Trust/Stable Governance↓ (OPPORTUNITY)◆
Sole proposal is trustee election; no contentious issues—low distraction for income-focused investors
Sector Themes (6)
- SPAC Survival Pressure◆
Plum Acquisition Corp's extension vote highlights ongoing SPAC distress; 2/3 majority requirement creates binary risk—similar to broader SPAC market where ~20% face liquidation in 2026
- Performance-Based Compensation Dominance◆
Kyndryl's 94% variable CEO pay with PSUs tied to OCF and TSR reflects industry trend; Cavco and Capri also link pay to operational metrics—aligning management with shareholders
- Governance Alignment in Asset Management◆
Nomura ETF Trust and HSBC Funds both propose board expansions/mergers to improve governance without cost increases—trend toward unified oversight across fund complexes
- Biotech Dilution vs. Clinical Progress◆
Silexion's 10M share increase for Nasdaq compliance and Phase 2/3 trials exemplifies biotech capital needs—dilution risk vs. potential upside from clinical catalysts
- Retail/Consumer Turnarounds◆
Capri (Versace sale) and Cavco (record revenue) show successful restructuring and growth in consumer sectors—focus on brand investment and operational efficiency
- Board Refreshment and Retirement◆
Driven Brands (Swinburn retiring) and HSBC Funds (adding 2 new trustees) indicate ongoing board refreshment—potential for new strategic perspectives
Watch List (8)
-
July 2, 2026 meeting; if approved, new deadline Jan 16, 2027; if not, liquidation at ~$10.67/share—binary event
-
Shareholder vote on 10M share increase and warrant exercisability; critical for Nasdaq compliance and clinical funding
-
Watch for specific revenue/earnings guidance and growth acceleration plans post-Versace sale
-
Monitor for updates on housing market headwinds and integration of American Homestar acquisition
-
New CFO, General Counsel, CHRO effective Feb 2026; watch for strategy shifts and Q1 FY2027 earnings
-
Virtual format; potential for strategic updates on streaming market position and subscriber growth
-
Board refresh after Swinburn retirement; watch for new director nominations and strategic direction
-
Trustee election for unified board; monitor for cost synergies and fund performance improvements
Filing Analyses
(10)
16-06-2026
Invesco Senior Income Trust (VVR) filed a definitive proxy statement (DEF 14A) for its joint annual shareholder meeting to be held on August 4, 2026. The sole proposal is the election of three trustee nominees: Beth Ann Brown, Jeffrey H. Kupor, and Anthony J. LaCava, Jr. The Board unanimously recommends voting FOR all nominees. VVR shareholders will vote in two separate groups: Common and Preferred shareholders together for Brown and Kupor (Proposal 1(a)), and Preferred shareholders separately for LaCava (Proposal 1(b)).
- · Meeting details: August 4, 2026, at 2:00 p.m. Central Daylight Time, location 11 Greenway Plaza, Houston, Texas.
- · Record date for voting eligibility: May 8, 2026.
- · No cumulative voting rights; each share entitles holder to one vote per proposal.
- · Proxies marked 'WITHHOLD' will be counted for quorum but not voted FOR the nominee, having the same effect as a vote against.
- · Under NYSE rules, brokers may vote in their discretion on trustee elections, so no broker non-votes are anticipated.
- · Proxy materials are available online at https://www.proxy-direct.com/inv-35110.
- · Approximate mailing date of proxy statement: June 30, 2026.
16-06-2026
HSBC Funds filed a definitive proxy statement (DEF 14A) on June 16, 2026, calling a special shareholder meeting for August 4, 2026 to elect seven trustee nominees, including two new independent trustees (Peter J. Hayes and Dawn M. Vroegop) who would begin service on or about October 1, 2026. The Board unanimously recommends voting FOR all seven nominees. The Board currently has five trustees, four of whom were previously elected by shareholders, and seeks shareholder approval to increase flexibility to appoint future trustees without incurring costs of additional shareholder meetings; the proposal arises from a governance 'best practice' perspective, not a legal requirement.
- · Record date for voting is June 1, 2026; proxy materials first mailed on or about June 22, 2026.
- · Meeting location is at State Street Bank and Trust Company, One Congress Street, 14th Floor, Room 1442, Boston, MA 02114.
- · Shareholders may also vote by mail, telephone, or internet; voting deadline not specified, but proxy may be revoked at any time prior to exercise.
- · If no instructions are given on returned proxy cards, the proxies will be voted FOR all nominees.
- · The annual shareholder report for the fiscal year ended October 31, 2025 was previously delivered to shareholders.
- · The proposal is not required by the 1940 Act but is presented as a corporate governance best practice.
16-06-2026
Plum Acquisition Corp. IV (PLMKW) filed a definitive proxy statement (DEF 14A) for an extraordinary general meeting on July 2, 2026, seeking shareholder approval to extend the business combination deadline from July 16, 2026, to January 16, 2027, with the option for monthly extensions up to July 16, 2027. The extension is needed because there is insufficient time to complete a proposed business combination with CTR by the current deadline. If the extension is not approved and no deal closes, Plum will be forced to liquidate and dissolve, with public shareholders receiving approximately $10.67 per share from the trust account, while warrants would expire worthless. The board recommends voting 'FOR' both the extension and adjournment proposals.
- · Meeting date: July 2, 2026 at 9:00 a.m. ET at Greenberg Traurig, P.A., West Palm Beach, FL.
- · Record date for voting: close of business on June 8, 2026.
- · Extension Amendment Proposal requires two-thirds majority of votes cast (special resolution).
- · Adjournment Proposal requires simple majority of votes cast (ordinary resolution).
- · Redemption deadline: must demand in writing and tender shares at least two business days prior to the initially scheduled meeting date.
- · If extension fails and no deal closes, Plum will cease all operations within 10 business days, redeem Public Shares, and dissolve.
- · Warrants will expire worthless in liquidation scenario.
- · A quorum failure means shares not counted for quorum or approval.
- · If proxy card is signed and returned without voting instructions, it will be voted FOR both proposals.
- · Public shareholders may redeem regardless of how they vote on the extension.
16-06-2026
Capri Holdings Ltd filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders to be held on July 29, 2026. The company reported a return to full-year profitability and positive free cash flow in Fiscal 2026, driven by strategic initiatives at Michael Kors and Jimmy Choo, and successfully completed the sale of Versace to strengthen its balance sheet. However, the filing does not provide specific revenue or earnings figures, and the focus remains on future growth acceleration and brand investment.
- · The company returned to full-year profitability and generated positive free cash flow in Fiscal 2026.
- · Capri successfully completed the sale of Versace, which strengthened the balance sheet and enhanced financial flexibility.
- · The Board fixed June 1, 2026 as the record date for the Annual Meeting, with 114,796,106 ordinary shares issued and outstanding.
- · Proposals include election of three Class III directors, ratification of Ernst & Young LLP as auditor, non-binding advisory vote on executive compensation, and approval of the Fifth Amended and Restated Omnibus Incentive Plan.
- · A quorum requires at least 50% of the votes of shares entitled to vote present in person or by proxy.
16-06-2026
FuboTV Inc. filed its definitive proxy statement (DEF 14A) on June 16, 2026, for the 2026 Annual Meeting of Stockholders to be held virtually on July 28, 2026. The filing covers executive compensation details for named executive officers including CEO David Gandler for fiscal years 2020-2025, and provides stockholder voting instructions and matters to be presented at the meeting.
- · The 2026 Annual Meeting is scheduled for July 28, 2026 at 12:00 p.m. ET via live webcast.
- · Stockholders need a 16-digit control number to participate and vote online.
- · The filing includes summary compensation table data for named executive officers spanning 2020-2025.
- · Preliminary proxy was not filed; this is the definitive proxy statement.
16-06-2026
Kyndryl Holdings, Inc. filed a DEF 14A proxy statement for the 2026 Annual Meeting, which includes an advisory vote on executive compensation (Say-on-Pay). The Compensation Discussion and Analysis details fiscal 2026 developments, including executive transitions (CFO, General Counsel, CHRO changes effective February 2026) and revised long-term equity incentive design with PSUs tied to cumulative three-year adjusted operating cash flow and a relative TSR modifier. CEO Martin Schroeter's target direct compensation was increased to $1,450,000 base salary, 225% bonus target, and an $18 million long-term incentive award, with 94% of target pay being variable.
- · The Board recommends stockholders vote FOR the advisory resolution to approve executive compensation.
- · The next Say-on-Pay advisory vote will occur at the 2027 Annual Meeting.
- · As of March 31, 2026, each non-employee director had 6,296 RSUs outstanding, vesting on July 30, 2026.
- · Fiscal 2026 annual cash bonus is earned based on revenue, adjusted EBITDA, and corporate citizenship goals, subject to individual performance adjustment.
- · PSU vesting for awards granted in fiscal 2026 is tied to a three-year adjusted operating cash flow performance objective with a relative TSR modifier based on the S&P MidCap 400 Index.
- · CEO Martin Schroeter's target direct compensation increase was determined by the independent Board members with input from the independent compensation consultant, considering post-spin performance and retention.
- · The CHC Committee revised PSU design to eliminate total signings metric.
16-06-2026
Silexion Therapeutics Corp is soliciting shareholder approval at an extraordinary general meeting for two proposals: (1) approval of exercisability of New Warrants and Placement Agent Warrants issued in a Warrant Inducement Transaction, and (2) an increase in authorized share capital by 10,000,000 ordinary shares. The company needs these approvals to maintain compliance with Nasdaq's $2.5 million minimum shareholders' equity requirement and to fund upcoming Phase 2/3 clinical trials for its lead candidate SIL 204. While the proposals are critical for continued listing and financing, the resulting share issuances could cause significant dilution and a drop in the trading price of ordinary shares.
- · Shareholders of record as of June 11, 2026 are entitled to vote; each ordinary share entitles one vote.
- · The company previously increased authorized share capital at a meeting on May 5, 2026, but subsequent transactions (Warrant Inducement, ATM sales, conversion of Moringa Sponsor Note) consumed most of that capacity.
- · The increase in authorized share capital itself does not cause dilution, but subsequent issuances to meet Nasdaq equity requirements will likely dilute existing holders and could reduce share price.
- · The company has only limited unissued authorized shares remaining beyond those reserved for existing commitments and near-term financing.
- · Voting can be done via internet, mail, or in person; virtual attendees cannot vote but can listen and submit questions.
16-06-2026
Nomura ETF Trust filed a definitive proxy statement (DEF 14A) on June 16, 2026, convening a joint special meeting of shareholders of nine ETFs for September 9, 2026. The sole proposal is to elect eleven trustees to create a single board overseeing both the Trust and the Nomura Funds mutual fund complex, aiming to align governance as the mutual fund and ETF worlds converge. The Board unanimously recommends voting 'FOR' each nominee, noting the change will not increase costs for current shareholders.
- · Record Date for voting is June 11, 2026.
- · Meeting will be held via live webstream only; credentials must be requested by 12:00 p.m. ET on September 8, 2026.
- · Two of the eleven nominees are current Trustees of the Trust; nine currently serve solely as trustees of the Nomura Funds.
- · Nomura Funds is described as 'largely a mutual fund complex.'
- · Proxy materials are available online at https://proxyvotinginfo.com/p/nomuraetfs2026.
- · Shareholders can vote by mail, telephone, or Internet, as well as virtually at the meeting.
16-06-2026
Driven Brands Holdings Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on July 28, 2026. The meeting will include the election of three Class III director nominees (Damien Harmon, Chadwick Hume, and Karen Stroup), an advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026. The record date is June 11, 2026, and the Board recommends a 'FOR ALL' vote on all proposals.
- · The annual meeting will be held in a virtual-only format at www.virtualshareholdermeeting.com/DRVN2026.
- · Stockholders of record as of June 11, 2026 are entitled to vote.
- · Peter Swinburn will retire from the Board at the end of his current term and will not stand for reelection.
- · Damien Harmon was appointed to the Board on January 1, 2024, and is now a Class III nominee.
- · The Board recommends a 'FOR ALL' vote for the three Class III director nominees.
16-06-2026
Cavco Industries filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held on July 28, 2026. The company reported record annual net revenue of approximately $2.2 billion and record home sales in fiscal year 2026, with income before income taxes increasing 15.9% and diluted EPS growing 15.8%. However, while the company completed its largest-ever acquisition (American Homestar Corporation) and repurchased $160M in stock, it also faces headwinds from evolving market conditions, interest rate dynamics, and housing affordability challenges.
- · Nearly 80% of Cavco's production facilities performed better than the industry average TRIR over the last year.
- · The company broke ground on a new state-of-the-art manufacturing facility in Arizona during fiscal year 2026.
- · The acquisition of American Homestar Corporation was the largest acquisition in Cavco's more than 60-year history.
- · The Board recognizes challenges including evolving market conditions, interest rate dynamics, and housing affordability challenges.
Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 10 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Compensation Proxy SEC Filings
🇺🇸 More from United States
View all →June 17, 2026
US Pre-Market SEC Filings Roundup — June 17, 2026
US Pre-Market SEC Filings Roundup
June 17, 2026
US Merger & Acquisition SEC Filings — June 17, 2026
US Merger & Acquisition SEC Filings
June 17, 2026
USA Insider Trading Pulse — June 17, 2026
USA Insider Trading Pulse
June 17, 2026
US Corporate Board Director Changes SEC Filings — June 17, 2026
US Corporate Board Director Changes SEC Filings